Skip to search formSkip to main contentSkip to account menu

magnesium orotate

Known as: Magnesium 2,6-Dioxo-3H-Pyrimidine-4-Carboxylate, Orotate Magnesium, Orotic Acid, Magnesium Salt 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Aim. To study the morphological features of loose fibrous connective tissue (LFCT) and myocardial contractility in patients with… 
2012
2012
year, were fol- ® (1500 mg/d) in three-month courses, twice a year, were fol- (1500 mg/d) in three-month courses, twice a year… 
2010
2010
Mitral valve prolapse (MVP) is a manifestation of the hereditary syndrome of differentiated or undifferentiated connective tissue… 
2010
2010
Orotic acid and its salts has been previously shown to improve the energy status of cardiomyocytes and to protect myocardium… 
2005
2005
: According to results of clinical and instrumental investigation magnesium orotate (50 mg/day during first week and 25 mg/day… 
2005
2005
According to results of clinical and instrumental investigation magnesium orotate (50 mg/day during first week and 25 mg/day… 
2005
2005
In series of papers the authors analyze the literature data concerned with clinical pharmacology of four main classes of… 
2000
2000
AIM To assess efficiency of magnerot, magnesium orotate, in patients with idiopathic mitral prolapse (IMP). MATERIAL AND… 
1998
1998
In a pilot study at 14 patients with coronary heart disease (CHD) and left-ventricular dysfunction (left ventricular enddiastolic…